These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10831083)
1. Towards a specific immunosuppression for pancreas and islet grafts. Jindal RM; Dubernard JM Clin Transplant; 2000 Jun; 14(3):242-5. PubMed ID: 10831083 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
3. Pancreas transplantation for treatment of diabetes mellitus. Sutherland DE; Gruessner RW; Gruessner AC World J Surg; 2001 Apr; 25(4):487-96. PubMed ID: 11344403 [TBL] [Abstract][Full Text] [Related]
4. Pancreas transplantation: is islet transplantation the future? Fernandez-Cruz L; Casanovas D; Lloveras G Transplant Proc; 1992 Dec; 24(6):2379-82. PubMed ID: 1465802 [No Abstract] [Full Text] [Related]
5. Preliminary experience with FK 506 in pancreas transplant recipients. Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Frisbie K; Cushing K Transplant Proc; 1995 Dec; 27(6):3024. PubMed ID: 8539823 [No Abstract] [Full Text] [Related]
6. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278 [No Abstract] [Full Text] [Related]
9. [Acute rejection of pancreatic grafts]. Guitián Pena A; Alonso Hernández A Nefrologia; 2010; 30(3):374-6. PubMed ID: 20514112 [No Abstract] [Full Text] [Related]
10. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation. Du CY; Xu EK Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281 [TBL] [Abstract][Full Text] [Related]
11. Role of tacrolimus in the evolution of liver transplantation. Busuttil RW; Lake JR Transplantation; 2004 May; 77(9 Suppl):S44-51. PubMed ID: 15201686 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. Rangel EB Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1585-605. PubMed ID: 25255841 [TBL] [Abstract][Full Text] [Related]
13. Islet transplantation: present and future perspectives. Kenyon NS; Ranuncoli A; Masetti M; Chatzipetrou M; Ricordi C Diabetes Metab Rev; 1998 Dec; 14(4):303-13. PubMed ID: 10095999 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation. Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546 [No Abstract] [Full Text] [Related]
18. [Pancreas and islet transplantation in diabetes mellitus]. Spinas GA; Diem P; Morel P Schweiz Med Wochenschr Suppl; 1994; 60():71-5. PubMed ID: 8016618 [No Abstract] [Full Text] [Related]
19. Post-transplant diabetes mellitus. The role of immunosuppression. Jindal RM; Sidner RA; Milgrom ML Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492 [TBL] [Abstract][Full Text] [Related]
20. Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. Jordan ML; Chakrabarti P; Luke PP; Shapiro R; Vivas CA; Scantlebury VP; Hakala TR; Fedorek S; Corry RJ Transplant Proc; 2001; 33(1-2):1655. PubMed ID: 11267456 [No Abstract] [Full Text] [Related] [Next] [New Search]